Skip to main content

Table 1 Number of staff questionnaires (Q), focus group discussions (FGD) and chart reviews by country/hospital site

From: Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries

Country

N Staff Q

N FGDs

Chart Reviews

   

N (m/f*)

Prospective review (% of all charts)**

Mean age (SD)

laboratory-confirmed

India

54

7

148 (106/42)

0

29 (14.4)

146 (99%)

Indonesia

115

6

389 (207/182)

303 (78%)

16 (10.8)

98 (25%)

Malaysia

92

5

353 (233/120)

336 (95%)

26 (14.4)

234 (66%)

Philippines

101

18

347 (174/173)

337 (97%)

14 (9.0)

0 (0)

Singapore

0

0

103 (60/43)

0

40 (14.2)

103(100%)

Saudi Arabia

187

6

299 (164/35)

179 (90%)

31 (13.0)

174 (87%)

Asia subtotal

549

42

1539 (944/959)

1155 (75%)

23 (14.6)

755 (49%)

Bolivia

137

5

256 (115/141)

194 (76%)

23 (15.3)

142 (55)

Brazil

0

0

94 (46/48)

0

37 (18.6)

93 (99)

Colombia

21

0

141 (68/73)

76 (54%)

14 (16.0)

59 (42)

Cuba

38

3

100 (39/61)

0

26 (19.3)

98 (98)

El Salvador

90

3

60 (30/30)

60 (100%)

8 (6.1)

56 (93)

Ecuador

70

4

72 (42/30)

54 (75%)

24 (18.9)

60 (83)

Mexico

58

0

38 (22/16)

38 (100%)

34 (19.2)

21 (55)

Nicaragua

108

2

528 (267/261)

346 (66%)

9 (6.9)

475 (90)

Paraguay

111

3

92 (36/56)

13 (14%)

36 (19.2)

46 (50)

Peru

80

0

117 (63/54)

39 (33%)

26 (16.4)

21 (18)

Puerto Rico

9

4

58 (30/28)

42 (72%)

27 (19.1)

31 (53)

Venezuela

17

5

153 (75/78)

75 (49%)

12 (11.3)

12 (8)

Latin America subtotal

739

29

1709 (833/876)

937 (55%)

19 (17.0)

1114 (65%)

Grand Total

1288

71

3248 (1777/1471)

2092 (64%)

21 (16.0)

1869 (58%)

  1. * m/f: male/female ratio; ** all charts include retrospective and prospective reviews